A Glimpse Into The Expert Outlook On Ionis Pharmaceuticals Through 5 Analysts
Media

A Glimpse Into The Expert Outlook On Ionis Pharmaceuticals Through 5 Analysts

Latest Ratings for IONS

Date Firm Action From To
Mar 2022 Guggenheim Initiates Coverage On Buy
Mar 2022 Citigroup Initiates Coverage On Sell
Feb 2022 SVB Leerink Maintains Market Perform

View More Analyst Ratings for IONS

View the Latest Analyst Ratings

read more

​ 

​Latest Ratings for IONS
DateFirmActionFromTo Mar 2022GuggenheimInitiates Coverage OnBuy Mar 2022CitigroupInitiates Coverage OnSell Feb 2022SVB LeerinkMaintainsMarket Perform
View More Analyst Ratings for IONS

View the Latest Analyst Ratings

read more 

Leave a Reply

Your email address will not be published. Required fields are marked *

This material is for informational purposes is not intended to be relied upon as a forecast, research or investment advice, and is not a recommendation, offer or solicitation to buy or sell any securities or to adopt any investment strategy. The opinions expressed are as of date of publication and are subject to change. Reliance upon information in this material is at the sole discretion of the reader. Past performance is not indicative of current or future results. This information provided is neither tax nor legal advice and investors should consult with their own advisors before making investment decisions. Investment involves risk including possible loss of principal.